Monday, 24 September 2018 16:16

Microbial Minutes: New Antibiotics, Vaccine Update, and Efficacy of Probiotics

Written by 
Published in mBiosphere

What's hot in the microbial sciences? ASM summarizes microbiology news and reports in Microbial Minutes, a biweekly news roundup. Watch the YouTube session for summaries and major findings, and read the reports and news coverage for yourself below. What should we highlight next time? Leave a suggestion in our comments section!

 

Attenuated Zika Virus may Fight Brain Cancer

Chen Q. et al. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate. mBio. Sept 18 2018.

 

Probiotic Efficacy Depends on Many Variables

Zmora N. et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics is Associated with Unique Host and Microbiome Features. Cell. September 6 2018.

Suez J. et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution is Impaired by Probiotics and Improved by Autologous FMT. Cell. September 6 2018.

 

Global Health Costs are Higher than the Current World Budget

Young R. et al. Developing New Health Technologies for Neglected Diseases: A Pipeline Portfolio Review and Cost Model. Gates Open Research. August 28 2018.

 

Protection from Influenza Vaccine Quickly Wanes

Ray G. et al. Intra-season Waning of Influenza Vaccine Effectiveness. Clinical Infectious Disease. September 10 2018. 

 

Scientists Develop New Drug Class to Fight Bacterial Infections

Smith PA et al. Optimized Arylomycins Are a New Class of Gram-Negative Antibiotics. Nature. September 12 2018. 

 

 

Antibiotic Combinations may Lengthen Efficacy of Current Drugs

Tekin E. Prevalence and Patterns of Higher-Order Drug Interactions in Escherichia coliSystems Biology and Applications. September 3 2018.

Last modified on Monday, 24 September 2018 16:36
Julie Wolf

Julie Wolf is the ASM Science Communications Specialist. She contributes to the ASM social media and blog network and hosts the Meet the Microbiologist podcast. She also runs workshops at ASM conferences to help scientists improve their own communication skills. Follow Julie on Twitter for more ASM and microbiology highlights at @JulieMarieWolf.

Julie earned her Ph.D. from the University of Minnesota, focusing on medical mycology and infectious disease. Outside of her work at ASM, she maintains a strong commitment to scientific education and teaches molecular biology at the community biolab, Genspace. She lives in beautiful New York City.

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

7500:microbial-minutes-new-antibiotics-vaccine-update-and-efficacy-of-probiotics